Article Versions Notes

Sabit H, Abbas S, El-Safoury MT, Madkour EM, Mahmoud S, Abdel-Ghany S, Albrahim Y, Al-Dhuayan IS, Rashwan S, El-Hashash A, et al. Antibody–Drug Conjugates in Breast Cancer: Navigating Innovations, Overcoming Resistance, and Shaping Future Therapies. Biomedicines. 2025; 13(9):2227. https://doi.org/10.3390/biomedicines13092227

Sabit, Hussein, Salma Abbas, Moataz T. El-Safoury, Engy M. Madkour, Sahar Mahmoud, Shaimaa Abdel-Ghany, Yasser Albrahim, Ibtesam S. Al-Dhuayan, Sanaa Rashwan, Ahmed El-Hashash, and et al. 2025. "Antibody–Drug Conjugates in Breast Cancer: Navigating Innovations, Overcoming Resistance, and Shaping Future Therapies" Biomedicines 13, no. 9: 2227. https://doi.org/10.3390/biomedicines13092227

Sabit, H., Abbas, S., El-Safoury, M. T., Madkour, E. M., Mahmoud, S., Abdel-Ghany, S., Albrahim, Y., Al-Dhuayan, I. S., Rashwan, S., El-Hashash, A., & Arneth, B. (2025). Antibody–Drug Conjugates in Breast Cancer: Navigating Innovations, Overcoming Resistance, and Shaping Future Therapies. Biomedicines, 13(9), 2227. https://doi.org/10.3390/biomedicines13092227